Cocktail of Growth Factors Including Fibroblast Growth Factor 9 (Cellcurin) Serum in the Treatment of Androgenetic Alopecia
May 2021
Studysummary In this randomized clinical trial, the use of Cellcurin serum for 12 weeks was associated with a significant increase in hair density and terminal hair thickness in individuals with androgenetic alopecia.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer